Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies
Ontology highlight
ABSTRACT: Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies
PROVIDER: PRJNA314451 | ENA |
REPOSITORIES: ENA
ACCESS DATA